Literature DB >> 7583588

Extracellular mast cell granules carry apolipoprotein B-100-containing lipoproteins into phagocytes in human arterial intima. Functional coupling of exocytosis and phagodytosis in neighboring cells.

M Kaartinen1, A Penttilä, P T Kovanen.   

Abstract

In experimental studies in vitro, mast cells have induced uptake of apolipoprotein B-100 (apoB-100)-containing low-density lipoproteins by macrophages, with the subsequent formation of foam cells, the hallmarks of atherosclerosis. Recently, increased numbers of activated, ie, degranulated, mast cells were found to be present in human coronary fatty streaks and atheromas. We therefore sought evidence of a connection between mast cells and foam cell formation in vivo. In electron microscopic studies of human aortic and coronary fatty streaks and atheromas, exocytosed cytoplasmic secretory granules of mast cells were detected in the vicinity of their parent cells. These exocytosed granules had bound apoB-100-containing lipoproteins, as indicated by their positive staining with MB 47, a monoclonal antibody against apoB-100. A smooth muscle cell was observed to be in the process of phagocytosing one such exocytosed granule, and in the vicinity of a degranulated mast cell a foam cell contained an ingested mast cell granule. Therefore, the micrographs show that exocytosed granules of intimal mast cells may contribute to intimal foam cell formation and suggest a role for mast cells in human atherogenesis. More generally, the findings provide evidence that phagocytosis of apoB-100-carrying particles is one mechanism by which lipoproteins enter human arterial intimal cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583588     DOI: 10.1161/01.atv.15.11.2047

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

Review 1.  Mast cells in atherogenesis: actions and reactions.

Authors:  Petri T Kovanen
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

2.  Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.

Authors:  Ilona Kareinen; Lídia Cedó; Reija Silvennoinen; Pirkka-Pekka Laurila; Matti Jauhiainen; Josep Julve; Francisco Blanco-Vaca; Joan Carles Escola-Gil; Petri T Kovanen; Miriam Lee-Rueckert
Journal:  J Lipid Res       Date:  2014-12-03       Impact factor: 5.922

3.  Characterization of mast cell populations using different methods for their identification.

Authors:  Dmitri Atiakshin; Vera Samoilova; Igor Buchwalow; Werner Boecker; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2017-02-27       Impact factor: 4.304

Review 4.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

Review 5.  Mast cells as effectors in atherosclerosis.

Authors:  Ilze Bot; Guo-Ping Shi; Petri T Kovanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-07       Impact factor: 8.311

6.  Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.

Authors:  L Lindstedt; M Lee; G R Castro; J C Fruchart; P T Kovanen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 7.  Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions.

Authors:  Petri T Kovanen
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

8.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.